BioCentury | Jan 9, 2021
Tools & Techniques

What DeepMind’s leap means for structure-based drug developers

...community through incorporation into popular tools like Rosetta...
BioCentury | Jul 26, 2019
Product Development

Institute for Protein Design's de novo revolution

...IPD's core technology is Rosetta, a computational platform for modeling, predicting and designing protein structures. Rosetta's...
...fit-for-purpose proteins that are completely unrelated to any proteins that have evolved in nature. Using Rosetta...
...with a Takeda build-to-buy deal, PvP Biologics developed its engineered gluten-degrading enzyme KumaMax by using Rosetta...
BioCentury | Apr 26, 2019
Company News

Institute for Protein Design awarded $45M for synthetic protein research

...therapeutics and drug delivery. The institute, led by David Baker, uses a computational platform called Rosetta...
...use in solar energy and nanofabrication. It also plans to hire staff to advance its Rosetta...
BioCentury | Dec 13, 2017
Preclinical News

Synthetic virus-like protein complexes could improve drug delivery

...of Washington, has previously designed artificial mini proteins using a computational protein design platform called Rosetta...
BioCentury | Oct 12, 2017
Product R&D

Artificial mini proteins

...molecules with the specificity of antibodies. The compounds were designed using a computational platform called Rosetta...
...“Mini-binding”). Figure: Mini-binding The Institute for Protein Design at the University of Washington used its Rosetta...
...the Rosetta platform and/or proteins designed with it. Arzeda Corp. , founded in 2008, uses Rosetta...
BioCentury | Sep 19, 2017
Company News

Management tracks: OncoMed, Vividion, Spero

...general counsel. She was EVP of patient access and corporate development and general counsel at Rosetta...
BioCentury | Dec 1, 2016
Financial News

Rosetta Genomics completes direct public offering and private placement

...and Maxim Group are placement agents for the offerings. Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Alex Himes Rosetta...
BioCentury | Oct 24, 2016
Product Development

A new BEAT for AML

.../ Novartis AG (NYSE:NVS; SIX:NOVN) Jakafi ruxolitinib JAK-1/JAK-2 inhibitor JAK-1/JAK-2 Ph II “We created a Rosetta...
BioCentury | Oct 3, 2016
Financial News

Dilafor completes venture financing

...2016-09-27 Type: Venture financing Raised: SEK51 million ($5.9 million) Investors: Lee’s Healthcare Industry Investment Ltd.; Rosetta...
BioCentury | Nov 2, 2015
Clinical News

RosettaGX Reveal: Clinical trial data

...international validation study showed that when the final diagnosis was unanimously confirmed by 3 pathologists, Rosetta’s...
...International Thyroid Congress and Annual Meeting of the American Thyroid Association in Lake Buena Vista. Rosetta...
Items per page:
1 - 10 of 307
BioCentury | Jan 9, 2021
Tools & Techniques

What DeepMind’s leap means for structure-based drug developers

...community through incorporation into popular tools like Rosetta...
BioCentury | Jul 26, 2019
Product Development

Institute for Protein Design's de novo revolution

...IPD's core technology is Rosetta, a computational platform for modeling, predicting and designing protein structures. Rosetta's...
...fit-for-purpose proteins that are completely unrelated to any proteins that have evolved in nature. Using Rosetta...
...with a Takeda build-to-buy deal, PvP Biologics developed its engineered gluten-degrading enzyme KumaMax by using Rosetta...
BioCentury | Apr 26, 2019
Company News

Institute for Protein Design awarded $45M for synthetic protein research

...therapeutics and drug delivery. The institute, led by David Baker, uses a computational platform called Rosetta...
...use in solar energy and nanofabrication. It also plans to hire staff to advance its Rosetta...
BioCentury | Dec 13, 2017
Preclinical News

Synthetic virus-like protein complexes could improve drug delivery

...of Washington, has previously designed artificial mini proteins using a computational protein design platform called Rosetta...
BioCentury | Oct 12, 2017
Product R&D

Artificial mini proteins

...molecules with the specificity of antibodies. The compounds were designed using a computational platform called Rosetta...
...“Mini-binding”). Figure: Mini-binding The Institute for Protein Design at the University of Washington used its Rosetta...
...the Rosetta platform and/or proteins designed with it. Arzeda Corp. , founded in 2008, uses Rosetta...
BioCentury | Sep 19, 2017
Company News

Management tracks: OncoMed, Vividion, Spero

...general counsel. She was EVP of patient access and corporate development and general counsel at Rosetta...
BioCentury | Dec 1, 2016
Financial News

Rosetta Genomics completes direct public offering and private placement

...and Maxim Group are placement agents for the offerings. Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Alex Himes Rosetta...
BioCentury | Oct 24, 2016
Product Development

A new BEAT for AML

.../ Novartis AG (NYSE:NVS; SIX:NOVN) Jakafi ruxolitinib JAK-1/JAK-2 inhibitor JAK-1/JAK-2 Ph II “We created a Rosetta...
BioCentury | Oct 3, 2016
Financial News

Dilafor completes venture financing

...2016-09-27 Type: Venture financing Raised: SEK51 million ($5.9 million) Investors: Lee’s Healthcare Industry Investment Ltd.; Rosetta...
BioCentury | Nov 2, 2015
Clinical News

RosettaGX Reveal: Clinical trial data

...international validation study showed that when the final diagnosis was unanimously confirmed by 3 pathologists, Rosetta’s...
...International Thyroid Congress and Annual Meeting of the American Thyroid Association in Lake Buena Vista. Rosetta...
Items per page:
1 - 10 of 307